(Q38122177)

29 August 2017

Delivering flavonoids into solid tumors using nanotechnologies (English)

1 reference

29 August 2017

0 references

Shengpeng Wang

1

1 reference

29 August 2017

Jinming Zhang

series ordinal

2

1 reference

29 August 2017

Meiwan Chen

series ordinal

3

1 reference

29 August 2017

Yitao Wang

series ordinal

4

1 reference

29 August 2017

language of work or name

English

0 references

publication date

18 July 2013

1 reference

Expert Opinion on Drug Delivery

29 August 2017

1 reference

29 August 2017

10

1 reference

29 August 2017

10

1 reference

29 August 2017

1411-1428

1 reference

Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention

29 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Lippia sidoides and Myracrodruon urundeuva gel prevents alveolar bone resorption in experimental periodontitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Effects of a herbal gel containing carvacrol and chalcones on alveolar bone resorption in rats on experimental periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Chemopreventive effects of natural dietary compounds on cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Molecular pathways for cancer chemoprevention by dietary phytochemicals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Balancing life-style and genomics research for disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Anticancer properties of flavonoids: roles in various stages of carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Absorption of three wine-related polyphenols in three different matrices by healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Polyamidoamine dendrimers as potential drug carriers for enhanced aqueous solubility and oral bioavailability of silybin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Cancer chemoprevention with dietary phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Dietary flavonoids and cancer risk: evidence from human population studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Estimation of antioxidant intakes from diet and supplements in U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Flavonoids: Promising anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Flavonoids: A versatile source of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Flavonoids: potential Wnt/beta-catenin signaling modulators in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Dietary flavonoids as cancer prevention agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Flavonoid-drug interactions: effects of flavonoids on ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Reversal of multidrug resitance by natural substances from plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Metabolism and bioavailability of flavonoids in chemoprevention: current analytical strategies and future prospectus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Quercetin glucosides interact with the intestinal glucose transport pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Commentary: bioavailability of flavonoids and polyphenols: call to arms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Bioavailability of dietary flavonoids and phenolic compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Overview of enzymes of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Natural polyphenol disposition via coupled metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Metabolism of flavonoids via enteric recycling: role of intestinal disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Disposition of flavonoids via enteric recycling: determination of the UDP-glucuronosyltransferase isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Fighting fire with fire: poisonous Chinese herbal medicine for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Targeting nanoparticles to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Cancer nanotechnology: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Ligand-targeted therapeutics in anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

The next frontier of molecular medicine: delivery of therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Advancement in multifunctional nanoparticles for the effective treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Tumor delivery of macromolecular drugs based on the EPR effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

The dawning era of polymer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Nanoparticle therapeutics: an emerging treatment modality for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Nanomedicine in cancer therapy: innovative trends and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Targeting multidrug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Nanoparticle-based combination therapy toward overcoming drug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Liposomal daunorubicin overcomes drug resistance in human breast, ovarian and lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

The flavonoid quercetin in disease prevention and therapy: facts and fancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Synergistic Effect of Functionalized Nickel Nanoparticles and Quercetin on Inhibition of the SMMC-7721 Cells Proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Multitargeted cancer prevention by quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Disposition of the Flavonoid Quercetin in Rats After Single Intravenous and Oral Doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Development of biodegradable nanoparticles for delivery of quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Preparation of a chemically stable quercetin formulation using nanosuspension technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Preparation and characterization of quercetin nanocrystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Enhancement of biological activities of nanostructured hydrophobic drug species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

ZnO-ZnS QDs interfacial heterostructure for drug and food delivery application: enhancement of the binding affinities of flavonoid aglycones to bovine serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Encapsulation of naturally occurring flavonoids into liposomes: physicochemical properties and biological activity against human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth facto

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Chemoprevention of head and neck cancer with green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

New cancer treatment strategy using combination of green tea catechins and anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Hepatotoxicity from green tea: a review of the literature and two unpublished cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Formulation and characterization of polyphenol-loaded lipid nanocapsules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Enhancement of cancer chemosensitization potential of cisplatin by tea polyphenols poly(lactide-co-glycolide) nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Nanochemoprevention by bioactive food components: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Layer-by-Layer-Coated Gelatin Nanoparticles as a Vehicle for Delivery of Natural Polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Soy isoflavones and cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Genistein and its synthetic analogs as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Inhibition of cancer cell invasion and metastasis by genistein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Improving the anti-tumor effect of genistein with a biocompatible superparamagnetic drug delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Apigenin: a promising molecule for cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Dietary agents in cancer prevention: flavonoids and isoflavonoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Nanotechnology in ligature-induced periodontitis: protective effect of a doxycycline gel with nanoparticules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Cytotoxicity of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Protective effect of locally applied carvacrol gel on ligature-induced periodontitis in rats: a tapping mode AFM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

The transport pathways of polymer nanoparticles in MDCK epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Monitoring the transport of polymeric micelles across MDCK cell monolayer and exploring related mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Chitosomes loaded with cranberry proanthocyanidins attenuate the bacterial lipopolysaccharide-induced expression of iNOS and COX-2 in raw 264.7 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Nanocarrier systems for oral drug delivery: do we really need them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Polyphenols: Chemistry, Dietary Sources, Metabolism, and Nutritional Significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

Dietary Flavonoids and the Risk of Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.807795

10.1517/17425247.2013.807795

21 January 2018

Identifiers

DOI

1 reference

release_5gp4b2k6q5gbrisnwmgos2rkvy

29 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5gp4b2k6q5gbrisnwmgos2rkvy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference